Sivelestat ameliorates sepsis-induced myocardial dysfunction by activating the PI3K/AKT/mTOR signaling pathway-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Sivelestat ameliorates sepsis-induced myocardial dysfunction by activating the PI3K/AKT/mTOR signaling pathway

Published:2024-02 Issue: Volume:128 Page:111466
ISSN:1567-5769
Container-title:International Immunopharmacology
language:en
Short-container-title:International Immunopharmacology

Author:

Geng Hongyu,Zhang Hongbo,Cheng Lianfang,Dong Shimin^ORCID

Publisher

Elsevier BV

Reference57 articles.

1. The third international consensus definitions for sepsis and septic shock (Sepsis-3);Singer;J. Am. Med. Assoc.,2016

2. Global, regional, and national sepsis incidence and mortality, 1990–2017: analysis for the Global Burden of Disease Study;Rudd;Lancet,2020

3. Sepsis Subclasses: A Framework for Development and Interpretation;DeMerle;Crit. Care Med.,2021

4. The Septic Heart: Current Understanding of Molecular Mechanisms and Clinical Implications;Martin;Chest,2019

5. Sepsis-induced cardiomyopathy: a review of pathophysiologic mechanisms;Flynn;Heart Fail. Rev.,2010

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combining ulinastatin with TIENAM improves the outcome of sepsis induced by cecal ligation and puncture in mice by reducing inflammation and regulating immune responses;International Immunopharmacology;2024-11

2. Nimbolide protects against diabetic cardiomyopathy by regulating endoplasmic reticulum stress and mitochondrial function via the Akt/mTOR pathway;Tissue and Cell;2024-10

3. Fucoidan improving spinal cord injury recovery: Modulating microenvironment and promoting remyelination;CNS Neuroscience & Therapeutics;2024-08

4. Quercetin Alleviates LPS-Stimulated Myocardial Injury through Regulating ALOX5/PI3K/AKT Pathway in Sepsis;Cardiovascular Toxicology;2024-07-28

5. Corrigendum to “Sivelestat ameliorates sepsis-induced myocardial dysfunction by activating the PI3K/AKT/mTOR signaling pathway” [Int. Immunopharmacol. 128 (2024) https://doi.org/10.1016/j.intimp.2023.111466];International Immunopharmacology;2024-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3